Table 4 Motives for EBUS execution
From: Useful on-site macroscopic quantitative evaluation of EBUS-TBNA samples
n | % | ||
|---|---|---|---|
Without previous diagnose | Lung micronodules/nodules and adenopathies | 24 | 19.84 |
Lung mass and adenopathies | 26 | 21.49 | |
Isolated adenopathies | 22 | 18.18 | |
With previous diagnose | Cancer staging | 28 | 23.14 |
Suspicion of cancer recurrence | 21 | 17.35 | |
Total | 121 | 100 | |